about
Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertensionAngiotensin-converting enzyme is involved in outside-in signaling in endothelial cellsFlotillin-1 facilitates toll-like receptor 3 signaling in human endothelial cellsDirect interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidaseNon-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cellsOptoinjection for efficient targeted delivery of a broad range of compounds and macromolecules into diverse cell types.Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal diseaseNox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteriesInhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.Phenotypic characterization of miR-92a-/- mice reveals an important function of miR-92a in skeletal development.Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase.Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.Elevated heart rate triggers action potential alternans and sudden death. translational study of a homozygous KCNH2 mutation.NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis.Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase.The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal MeningitisSympathoactivation and rho-kinase-dependent baroreflex function in experimental renovascular hypertension with reduced kidney mass.A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysmAn endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice.Micro-CT Technique Is Well Suited for Documentation of Remodeling Processes in Murine Carotid Arteries.The Histone Demethylase PHF8 Is Essential for Endothelial Cell Migration.Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.Vascular NADPH oxidases: molecular mechanisms of activation.Metabolism Regulates Cellular Functions of Bone Marrow-Derived Cells used for Cardiac Therapy.The NADPH Oxidase Nox2 Mediates Vitamin D-Induced Vascular Regeneration in Male Mice.NADPH oxidase 4 regulates homocysteine metabolism and protects against acetaminophen-induced liver damage in miceTargeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2α-mediated stress signalingThe NADPH oxidase Nox4 has anti-atherosclerotic functions.Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane traffickingWhich NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.The Endoplasmic Reticulum Chaperone Calnexin Is a NADPH Oxidase NOX4 Interacting Protein.CRISPR/Cas9-mediated knockout of p22phox leads to loss of Nox1 and Nox4, but not Nox5 activity.NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxia.Inhibition of the soluble epoxide hydrolase by tyrosine nitration.
P50
Q21284417-CD9DF312-2D23-4544-A48E-40592FF0BC3CQ24299714-0B5B35AB-7FE1-447C-9FBD-550984DEF833Q24303910-32DC049A-A431-449D-A171-6D4508DD8F2FQ28277982-DD702723-0894-43DF-887E-719842D72B0EQ28306609-551D55C1-4132-4468-B015-76BCA32ED221Q33235934-2871CDED-D5EC-4DDD-8143-72A503EE07D4Q33257976-CB5835E9-1F48-4BD9-B0E4-406A430D25CEQ33652488-750CE568-DDC0-4BBD-A809-CED7C9F616D0Q33744942-060A858C-9464-4D52-BF97-111F1E8F99B9Q33824233-4F4284E2-6851-4981-8C0A-2B1A1B3D3F8FQ33825778-5FC5AF3A-F978-4B4F-A430-143AB9ADD575Q33887169-0DD278F0-EEB9-4F2F-AF4E-CA25D7DEAC97Q34056717-A3A7F2B9-24CC-41BB-B437-79F2296C5038Q34070289-39923ECC-CB71-40BE-9A76-CA5FDBA7FEF2Q34241578-28404E4A-CCB4-4B31-8242-64A1D7D1D799Q34264162-6362162C-0F41-4902-B46E-56A898925AD0Q34276697-5EC5B0A8-A15E-4DB5-9114-4E849C28F31EQ34628594-7562392F-4141-4507-BB86-8E9337FE81EAQ34787163-17C300D3-CFFD-4047-BC25-25DE735EE628Q35045451-3555A6C1-EBF6-4476-8EE5-97B8EA5EB75EQ35106470-9FBA193B-D204-42B4-BE11-37EDFB77CA79Q35191565-4CC26365-C0D3-4718-8292-CC605653C97DQ35195538-3C668A8B-3682-491E-9132-13D618DA994EQ35214463-E6CA4589-E37C-41EE-B6A4-8E0C4A7608D7Q35666949-E9C6E42C-9F44-4557-9CFF-ECA50D3F0EBEQ35890073-4F781710-C808-4F0E-9C7E-859F4A530A4DQ35893594-6E790701-9EA5-475D-9356-AC78C13BFD80Q35994483-8FEB43FE-62C2-4DB0-BDCB-BED2250DA916Q36008423-85644233-B8D3-4909-AEA8-E1FF36A636D4Q36072675-EBA8E56A-0DC6-4E73-9931-ACCEE71F4CF6Q36422396-F5E2A039-6475-445C-8233-393A9EC62753Q36543727-55F71E39-A373-4345-9064-676E1AD85959Q36573517-FCFF38B3-0D7C-46A4-AA81-FCA9F9BDEB8FQ36578488-048B0BC5-4BB7-4320-832C-02CFAE8B4E8DQ36702523-950706D2-B6EC-4AF3-BAF1-48FCAA986D1DQ36727443-255504EC-475C-48CA-B82D-F3200648683CQ37253863-DA6C7A81-12C3-48BA-AFA2-A6B68B92D9E5Q37259220-B16EB2CF-7CFE-4124-90E3-3641B7E6C1D7Q37297962-40986272-9125-461B-923E-E8079368AD26Q37459953-4B1C515C-00BF-4829-9140-1692AB5F7286
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ralf P. Brandes
@ast
Ralf P. Brandes
@en
Ralf P. Brandes
@es
Ralf P. Brandes
@nl
Ralf P. Brandes
@sl
type
label
Ralf P. Brandes
@ast
Ralf P. Brandes
@en
Ralf P. Brandes
@es
Ralf P. Brandes
@nl
Ralf P. Brandes
@sl
prefLabel
Ralf P. Brandes
@ast
Ralf P. Brandes
@en
Ralf P. Brandes
@es
Ralf P. Brandes
@nl
Ralf P. Brandes
@sl
P1053
L-3058-2017
P106
P1153
35428991000
P21
P31
P3829
P496
0000-0002-8035-0048